This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
FY26 revenue up 27.4%, profit after tax up 293%; AGM seeks related party approvals
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.4 pts more than Nifty Microcap 250 and 2.9 pts more than its Trading - Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Evexia Lifecare's FY26 audited results show consolidated revenue rising 27.4% to Rs 11,027.49 lakh and profit after tax up 293% to Rs 162.13 lakh. Standalone revenue grew 25.7% to Rs 10,546.46 lakh and profit after tax rose 108.9% to Rs 152.11 lakh. At the 35th AGM on 30 September 2026, shareholders will approve material related party transactions with group companies, each capped at Rs 200 crore for FY27.
Stronger sales and profit support the stock, but related party transaction limits with group firms raise governance risks for minority holders.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹25.02 Cr | ₹25.73 Cr | −2.8% |
| Operating profit | −₹0.43 Cr | ₹0.07 Cr | −680.3% |
| Profit after tax | ₹0.23 Cr | ₹0.37 Cr | −37.9% |
| EBITDA margin | -0.3% | 0.4% | −0.7 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.